Clinical Trials Sponsored by Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives

Total 31 results

Groupe d'Etude Therapeutique des Affections Inflammatoires...

Active, not recruiting

Role of Capsule Endoscopy in the Evaluation of Mucosal Changes During Treatment of Patients With Active Crohn's Disease (CHANCE)

Crohn's Disease

Spain, France
Groupe d'Etude Therapeutique des Affections Inflammatoires...

Completed

Evaluation of Digestive Damage and Associated Predictive Factors in Crohn's Disease 5 to 10 Years After Diagnosis (DESTIN)

Crohn's Disease

France
Groupe d'Etude Therapeutique des Affections Inflammatoires...

Completed

A Study Evaluating the Impact of an Educational Program (EDU-MICI) on Patients With Inflammatory Bowel Disease (ECIPE)

Crohn's Disease | Ulcerative Colitis

France
Groupe d'Etude Therapeutique des Affections Inflammatoires...

Not yet recruiting

Identification of Factors ASsociaTed With a Delayed Diagnosis in Crohn's Disease (FAST)

Crohn Disease
Groupe d'Etude Therapeutique des Affections Inflammatoires...

Completed

A Randomized, Multicenter Open Label Study Comparing Early Administration of Azathioprine Plus IFX to Steroids Plus Azathioprine for Acute Severe Colitis (ACTIVE)

Ulcerative Colitis

France
Groupe d'Etude Therapeutique des Affections Inflammatoires...

Completed

Intensive Treatment to Reach the Target With Golimumab in ulcErative coliTis - In-TARGET (In-TARGET)

ULCERATIVE COLITIS

France, Belgium
Groupe d'Etude Therapeutique des Affections Inflammatoires...

Completed

Study Investigating Tailored Treatment With Infliximab for Active Crohn's Disease (TAILORIX)

Crohn's Disease

France
Groupe d'Etude Therapeutique des Affections Inflammatoires...

Completed

CE-U and MRE to Predict the Efficacy of Anti-TNF Therapy in Crohn's Disease (CREOLE)

Crohn's Disease

France, Belgium
Groupe d'Etude Therapeutique des Affections Inflammatoires...

Completed

Endoscopic Severity Score of Small Bowel Crohn's Disease With Wireless Capsule Endoscopy (CAPSCDEIS)

Crohn's Disease

France, Belgium
Groupe d'Etude Therapeutique des Affections Inflammatoires...

Completed

Study Comparing Cyclosporine With Infliximab in Steroid-refractory Severe Attacks of Ulcerative Colitis (CYSIF)

Ulcerative Colitis | Steroid Refractory

France, Spain, Belgium, Finland, Italy
Groupe d'Etude Therapeutique des Affections Inflammatoires...

Recruiting

TRansmural hEaliNg Definition in CroHn's Disease (TRENCH 1) (TRENCH 1)

Crohn Disease

Belgium, France
Groupe d'Etude Therapeutique des Affections Inflammatoires...

Active, not recruiting

Changing the coUrse of cRohn's Disease With an Early Use of Adalimumab (CURE)

CD

France, Belgium
Groupe d'Etude Therapeutique des Affections Inflammatoires...

Completed

IBD Cancer and Serious Infection in Europe (I-CARE)

IBD

France
Groupe d'Etude Therapeutique des Affections Inflammatoires...

Completed

Predictive Factors of ANTI-TNF Response in Luminal Crohn's Disease Complicated by Abscess (MICA)

CD

France
Groupe d'Etude Therapeutique des Affections Inflammatoires...

Completed

Endoscopic Detection of Dysplasia in Crohn 's Disease Patient (DYDJI)

Crohn Disease Located in Jejunum or Ileum

France
Groupe d'Etude Therapeutique des Affections Inflammatoires...

Terminated

Comparison of Ferrisat vs Placebo in Anemia Associated to Inflammatory Bowel Disease During Anti-TNF Therapy (FER)

Inflammatory Bowel Disease

France
Groupe d'Etude Therapeutique des Affections Inflammatoires...

Completed

Evaluation of the Applicability of the CDEIS to Data Obtained by the Colonic Capsule Endoscopy in Crohn Disease (CAPSCOL)

Crohn Disease

France
Groupe d'Etude Therapeutique des Affections Inflammatoires...

Completed

Comparison Azathioprine to Mesalazine for the Prevention of Postoperative Recurrence in the Crohn Disease (IMURELPOST)

Crohn Disease

France
Groupe d'Etude Therapeutique des Affections Inflammatoires...

Completed

Stop Infliximab in Patients With Crohn's Disease (STORI)

Crohn Disease

France, Belgium
Groupe d'Etude Therapeutique des Affections Inflammatoires...
Takeda

Recruiting

VeDOlizumab PERsistence in IBD Patients After Switching From Intravenous to Subcutaneous Administration : a Real-life Multicenter Study (DOPER) (DOPER)

Inflammatory Bowel Diseases

France
Groupe d'Etude Therapeutique des Affections Inflammatoires...
AbbVie

Recruiting

A Trial COmparing staNdard of Care Versus Treat to Target With telemonitoRing and Patient Education in Patients With Ulcerative cOlitis Initiating Adalimumab (CONTROL)

Ulcerative Colitis

France
Groupe d'Etude Therapeutique des Affections Inflammatoires...
Celltrion

Active, not recruiting

A 24-month Real Life PErsistence Efficacy and Safety Study in IBD Patients in REMission Switched From Intravenous Infliximab to Subcutaneous Infliximab CT-P13 Remsima®SC (PEREM)

Inflammatory Bowel Diseases

France
Groupe d'Etude Therapeutique des Affections Inflammatoires...
Janssen, LP

Recruiting

USTekinumab in Fistulising Perianal Crohn's Disease (USTAP) (USTAP)

Crohn's Disease

France
Groupe d'Etude Therapeutique des Affections Inflammatoires...
Sanoia

Not yet recruiting

Ibd CAncer and seRious Infections in France (I-CARE 2) (I-CARE 2)

Crohn Disease | Ulcerative Colitis | IBD

France
Groupe d'Etude Therapeutique des Affections Inflammatoires...
Celltrion

Recruiting

Management of Moderate POstoperative Recurrence in Crohn's Disease: a randoMizEd contROLled Trial of Therapeutic Escalation, the POMEROL Trial. (POMEROL) (POMEROL)

Crohn Disease

France
Nantes University Hospital
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives

Not yet recruiting

Medical Treatment Versus Surgery in Stricturing Small Bowel Crohn's Disease (SMART)

Crohn Disease
Groupe d'Etude Therapeutique des Affections Inflammatoires...
Société Nationale Française de Gastroentérologie

Completed

Early Immunosuppressants in Crohn's Disease (RAPID)

Crohn's Disease

France
Groupe d'Etude Therapeutique des Affections Inflammatoires...
Saint-Louis Hospital, Paris, France

Completed

A proSpective Randomized Controlled Trial comParing infliximAb-antimetabolites Combination Therapy to Anti-metabolites monotheRapy and Infliximab monothErapy in Crohn's Disease Patients in Sustained Steroid-free Remission on Combination Therapy (SPARE)

Crohn's Disease

Australia, Belgium, France
Groupe d'Etude Therapeutique des Affections Inflammatoires...
Société Nationale Française de Gastroentérologie; Nycomed

Completed

Fibrin Glue for Perianal Fistulas in Crohn's Disease: a Randomized Controlled Trial (Fibrin glue)

Crohn's Disease

France, Belgium
Groupe d'Etude Therapeutique des Affections Inflammatoires...
AbbVie; Gilead Sciences; Roche Pharma AG; Takeda; Celgene; Biogen

Completed

Crohn's Disease Endoscopic REmission Definition in an Objective Way (CREDO1)

CD

Belgium, France
Groupe d'Etude Therapeutique des Affections Inflammatoires...
AbbVie; Gilead Sciences; Roche Pharma AG; Takeda; Celgene; Biogen

Active, not recruiting

Is the Endoscopic Remission Evaluation, Using the CREDO 1 Index / Score in CD Patients in Clinical Remission at Baseline, Predictive of Sustained Clinical Remission Using a 2-year Follow up (CREDO2)

CD

Belgium, France

Clinical Trials Sponsored by Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Serbia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations